Drew Smith

This inventor holds 9 USPTO granted patents and 1 published patent application. Top assignees: Nexstar Pharmaceuticals, Inc., Gilead Sciences, Inc.. Active years: 1997-2007.

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 88.9

Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 680(Granted Patents)

Company Filing History:

6 out of 131

Nexstar Pharmaceuticals, Inc.

patents

3 out of 946

Gilead Sciences, Inc.

patents

Years Active: 1997-2007

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7176295 - Systematic evolution of ligands by exponential enrichment: blended SELEX (2007-02-13),

2. 6465189 - Systematic evolution of ligands by exponential enrichment: blended selex (2002-10-15),

3. 6300074 - Systematic evolution of ligands by exponential enrichment: Chemi-SELEX (2001-10-09),

4. 6083696 - Systematic evolution of ligands exponential enrichment: blended selex (2000-07-04),

5. 5998142 - Systematic evolution of ligands by exponential enrichment: chemi-SELEX (1999-12-07),

6. 5962219 - Systematic evolution of ligands by exponential enrichment: chemi-selex (1999-10-05),

7. 5763595 - Systematic evolution of ligands by exponential enrichment: Chemi-SELEX (1998-06-09),

8. 5705337 - Systematic evolution of ligands by exponential enrichment: chemi-SELEX (1998-01-06),

9. 5683867 - Systematic evolution of ligands by exponential enrichment: blended SELEX (1997-11-04),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

1 patent pending:

Please report any incorrect information to [email protected]